Oral and vaginal misoprostol 800 μg every 8 h for early abortion

Contraception

Volumn 67, Issue 6, 2003, Pages 457-462

  Carbonell, J L L ^a   Rodriguez J ^b   Velazco, A ^b   Tanda, R ^b   Sanchez C ^b   Barambio, S ^c   Chami, S ^d   Valero, F ^e   Mari J ^a   De Vargas, F ^f   Salvador, I ^a  

^a Mediterranea Medica Clinic   (Spain)

^b Hosp Docente Gineco Obstetrico E   (Cuba)

^c Clinica Tutor Medica   (Spain)

^d Clinica Isadora   (Spain)

^e Clinica Delta Medica   (Spain)

^f Centre Medic Naturista   (Spain)

Author keywords

Abortion; Misoprostol

Indexed keywords

MISOPROSTOL;

ADULT; ARTICLE; CHILL; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; DRUG SELF ADMINISTRATION; EVALUATION; FEMALE; FEVER; GESTATIONAL AGE; HUMAN; INDUCED ABORTION; MEASUREMENT; MEDICAL ASSESSMENT; NAUSEA; NORMAL HUMAN; PREGNANCY TERMINATION; SIDE EFFECT; SPONTANEOUS ABORTION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; UTERINE BLEEDING PATTERN; VAGINA BLEEDING; VERTIGO; VOMITING;

EID: 0038176475     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-7824(03)00043-X     Document Type: Article

References (29)

1. Gemzell K.D., Marions L., Rodriguez A., et al. Comparison between oral and vaginal administration of misoprostol on uterine contractility. Obstet Gynecol. 93:1999;275-280.
2. 1 methyl analogue misoprostol on the pregnant human uterus in the first trimester. Geburtshilfe Frauenheilkd. 47:1987;324-331.
3. Bugalho A., Mocumbi S., Faúndes A., David E. Termination of pregnancies of <6 weeks gestation with a single dose of 800 μg of vaginal misoprostol. Contraception. 61:2000;47-50.
4. Aubeny E, Missey H. Interruption volontaire de grossesse par le RU 486. La Revue du practicien, Medicine genérale, tome 10, no 358, 11 Nov 1996.
5. Peyron R., Aubeny E., Targosz V., et al. Early termination of pregnancy with mifepristone (RU-486) and the orally active prostaglandin misoprostol. N Engl J Med. 328:1993;1509-1513.
6. Aubeny E. Evolution depuis 1989, en France, des interruptions volontaires de grossesse par mifepristone (RU 486) associée a un analogue de prostaglandine. Contracept Fertil Sex. 25:1997;777-781.
7. Carbonell J.L.L., Varela L., Velazco A., Cabezas E., Fernández C., Sánchez C. Misoprostol three, four or five days after methotrexate for early abortion; a randomized trial. Contraception. 56:1997;169-174.
8. Creinin M.D., Vittinghoff E., Keder L., et al. Methotrexate and misoprostol for early abortion a multicenter trial. I. Safety and efficacy . Contraception. 53:1996;321-327.
9. Carbonell J.L.L., Varela L., Velazco A., Cabezas E., Fernández C., Sánchez C. 25 or 50 mg of oral methotrexate followed by vaginal misoprostol seven days later for early abortion. Obstet Gynecol Invest. 153:1999;1410-1418.
10. Creinin M.D. Oral methotrexate and vaginal misoprostol for early abortion. Contraception. 54:1996;15-18.
11. Carbonell J.L.L., Varela L., Velazco A., Fernández C. The use of misoprostol for termination of early pregnancy. Contraception. 55:1997;165-168.
12. Carbonell J.L.L., Varela L., Velazco A., et al. The use of misoprostol for abortion of ≤9 weeks gestation. Eur J Contract Rep Health C. 2:1997;181-185.
13. Carbonell J.L.L., Varela L., Velazco A., et al. Early abortion with 800 μg of misoprostol by the vaginal route. Contraception. 59:1999;219-225.
14. Carbonell J.L.L., Barambio S., Chami S., et al. Dosis residuales post-aborto con misoprostol. Ensayo clínico aleatorizado. Prog Obstet Ginecol. 43:2000;233-236.
15. Carbonell J.L.L., Varela L., Velazco A., Cabezas E., Tanda R., Sánchez C. Vaginal misoprostol for late first trimester abortion. Contraception. 57:1998;329-333.
16. Carbonell J.L.L., Varela L., Velazco A., Tanda R., Sánchez C. Vaginal misoprostol for abortion at 10-13 weeks' gestation. Eur J Contracept Rep Health C. 4:1999;1-6.
17. Velazco A., Varela L., Tanda R., et al. Misoprostol for abortion up to 9 weeks gestation in adolescents. Eur J Contracept Rep Health C. 5:2000;227-233.
18. Carbonell J.L.L., Varela L., Tanda R., et al. Misoprostol for abortion at 9-12 weeks gestation in adolescents. Eur J Contracept Rep Health C. 6:2001;39-45.
19. Patuszack A.L., Schüler L., Speck-Martins C.E., et al. Use of misoprostol during pregnancy and Möbius syndrome in infants. N Engl J Med. 338:1998;1881-1885.
20. Gonzalez C.H., Marques-Dias M.J., Kim C.A., et al. Congenital abnormalities in Brazilian children associated with misoprostol misuse in first trimester of pregnancy. Lancet. 351:1998;1624-1627.
21. Hellman L.M., Kobayashi M., Fillisti L., et al. Growth and development of the human fetus prior to twentieth week of gestation. Am J Obstet Gynecol. 103:1969;789-800.
22. Goldstein S., Wolfson R. Endovaginal ultrasonographic measurement of early embryonic size as a mean of assessing gestational age. J Ultrasound Med. 13:1994;27-31.
23. Harwood B., Meckstroth K.R., Mishell D.R., Jain J.K. Serum beta-human chorionic gonadotropin levels and endometrial thickness after medical abortion. Contraception. 63:2001;255-256.
24. Mishell D.R., Jain J.K., Byrne J.D., Lacarra M.D.C. A medical method of early pregnancy termination using tamoxifen and misoprostol. Contraception. 58:1998;1-6.
25. Jain J.K., Harwood B., Meckstroth K.R., Mishell D.R. Early pregnancy termination with vaginal misoprostol combined with loperamide and acetaminophen prophylaxis. Contraception. 63:2001;217-221.
26. Carbonell J.L.L., Aragón S., Velazco A., et al. Vaginal misoprostol 1000 μg for early abortion. Contraception. 63:2001;131-136.
27. Carbonell J.L.L., Varela L., Rodriguez J., et al. Oral versus vaginal misoprostol for cervical priming in first trimester abortion. A randomized trial. Eur J Contracept Rep Health C. 6:2001;134-140.
28. El-Refaey H., Fajasekar D., Abdalla I.M., et al. Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol. N Engl J Med. 332:1995;983-987.
29. Zieman M., Fong S.K., Benowitz N.L., et al. Absorption kinetics of misoprostol with oral or vaginal administration. Obstet Gynecol. 90:1997;88-92.